Infusion Pumps and Devices: Technologies and Global Markets

Aug 2022| HLC071D| BCC Publishing
Sample Report

Report Highlights

The global market for infusion pumps was valued at $9.8 billion in 2021 and is estimated to grow from $10.3 billion in 2022 to $15.0 billion in 2027 with compound annual growth rate (CAGR) of 7.7% for the period of 2022-2027.

Report Includes

  • 34 data tables and 69 additional tables.
  • An overview of the global market and technologies for infusion pumps and devices
  • Estimation of the market size and analyses of global market trends, with data from 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2027
  • Coverage of medical, scientific, technological, social, and economic issues associated with this market and evaluation of the current market and variable factors of each category of diagnostic or therapeutic product
  • Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls
  • Examination of the transition to "smart pump" technology and the complex systems that complement and compete with infusion pumps as modes of treatment
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
  • Company profiles of major players, including Intera Oncology, ICU Medical Inc, Cardinal Health and ZYNO Solution LLC

     

Report Scope

This report aims to provide a comprehensive picture of the global market for infusion pumps, with both quantitative and qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding infusion pumps.

An in-depth analysis of the global infusion pumps market includes historical data and market projections on sales by pump type, therapeutic application, end user, and region. The analysis describes the different types of infusion pumps (general purpose and specialty) and their current and historical market revenues. The general purpose infusion pumps are categorized into large volume, syringe, electronic ambulatory, and elastomeric. The specialty infusion pumps are divided into insulin infusion pumps, enteral infusion pumps, PCA infusion pumps, and implantable infusion pumps.

This report also examines therapeutic applications for infusion pumps (diabetes management, oncology, pain management/analgesia, nutrition, and other applications) and end users of infusion pumps (hospitals, home care and alternate site care settings).

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors and their respective market ranks. The report also discusses technological trends and new product developments.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022–2027
Base year market size $9.8 billion
Market size forecast $15.0 billion
Growth rate CAGR of 7.7% from 2022 to 2027
Units considered $ Millions
Segments covered Product Type, Region, Company, End User, Therapeutic Application
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered United States., Canada., Germany., France., U.K., Italy., Rest of Europe (Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Russia)., China., Japan., India., Rest of Asia-Pacific (Australia, South Korea, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Indonesia)., Latin America., Middle East and Africa.
Key Market Drivers
  • Growing and Aging Population
  • The Growing Number of Chronically Ill and Multimorbid Patients
  • Rising Demand for Ambulatory Infusion Pumps, Especially in Home Care Settings
  • Technological Advancements
  • Increasing Number of Global Surgeries
  • Rising Demand in Emerging Markets
  • Rising Expectations for Increasing Quality of Care
Companies studied
ABBOTT LABORATORIES
AMSINO INTERNATIONAL INC.
AVANOS MEDICAL INC.
B. BRAUN MELSUNGEN AG
BAXTER INTERNATIONAL INC.
BECTON, DICKINSON AND CO.
CARDINAL HEALTH
EITAN MEDICAL LTD.
FLOWONIX MEDICAL INC.
FRESENIUS KABI AG
ICU MEDICAL INC.
INSULET CORP.
INTERA ONCOLOGY
IRADIMED CORP.
KORU MEDICAL SYSTEMS
MEDTRONIC PLC
MICREL MEDICAL DEVICES SA
MOOG, INC.
NESTLE HEALTH SCIENCE
ROCHE DIAGNOSTICS
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
TANDEM DIABETES CARE INC.
TERUMO CORP.
ZYNO SOLUTIONS LLC

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Infusion Pumps and Devices: Technologies and Global Markets164 $5,500 Free
Chapter- 1: Introduction6Free DownloadFree
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Market and Technology Background5$170Free
Chapter- 4: Market Dynamics11$373Free
Chapter- 5: Market Breakdown by Product Type21$713Free
Chapter- 6: Market Breakdown by Region18$611Free
Chapter- 7: Market Breakdown by Therapeutic Application10$340Free
Chapter- 8: Market Breakdown by End User13$441Free
Chapter- 9: Regulatory Structure8$272Free
Chapter- 10: Impact of COVID-193$102Free
Chapter- 11: Competitive Landscape9$306Free
Chapter- 12: Company Profiles56$1,901Free
Chapter- 13: Appendix: List of Acronyms2$68Free
Published - Nov-2016| Analyst - Shalini Shahani Dewan| Code - HLC071C

Report Highlights

The global market for infusion pumps and devices reached $18.5 billion in 2015. The market should reach $19.6 billion in 2016 and nearly $25.8 billion by 2021, growing at a compound annual growth rate (CAGR) of 5.6% from 2016 to 2021.

Report Includes

  • An overview of the global market for infusion pumps used for continuous or intermittent administration of medications (including antibiotics), nutrients, and analgesics.
  • Analyses of global market trends with data from 2014 and 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Coverage of medical, scientific, technological, social, and economic issues associated with this market.
  • Evaluation of the current market and variable factors of each category of diagnostic or therapeutic product.
  • Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls.
  • Examination of the transition to "smart pump" technology and the complex systems that complement and compete with infusion pumps as modes of treatment.
  • Profiles of major players in the industry.

Published - Sep-2013| Analyst - Shalini Shahani Dewan| Code - HLC071B

Report Highlights

The global revenue for the infusion pumps and devices market reached $17.8 billion in 2012. This market is expected to grow to $18.7 billion in 2013 and then to $23.7 billion by 2018 at a compound annual growth (CAGR) of 4.8% from 2013-2018.

Report Includes

  • An overview of the global market for infusion pumps used for continuous or intermittent administration of medications (including antibiotics), nutrients, and analgesics
  • Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • Coverage of medical, scientific, technological, social, and economic issues associated with this market
  • Evaluation of the current market and variable factors of each category of diagnostic or therapeutic product
  • Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls
  • Examination of the transition to “smart pump” technology and the complex systems that complement and compete with infusion pumps as modes of treatment
  • Comprehensive company profiles of major players in the industry.

Published - Feb-2010| Analyst - Thomas Fuller| Code - HLC071A

Report Highlights

  • Global spending on infusion pumps were $6.4 billion in 2008 which increased to $7 billion in 2009. This is projected to reach $9.6 billion in 2014 at a compound annual growth rate (CAGR) of 6.5%
  • Spending alone in USA was nearly $3.3 billion in 2008 which increased to $3.6 billion in 2009. This is projected to reach $4.8 billion in 2014 at a compound annual growth rate (CAGR) of 5.8%
  • Spending in Europe was $1.9 billion in 2008, which increased slightly in 2009 to $2 billion. This market is projected to reach approx $2.8 billion in 2014, for a 5-year CAGR of 6.4%.

Infusion Pumps and Devices: Technologies and Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS